Cellid, Co., Ltd. (299660.KQ)

KRW 5500.0

(-7.25%)

Net Income Summary of Cellid, Co., Ltd.

Cellid, Co., Ltd.'s latest annual net income in 2023 was -11.61 Billion KRW , up 49.22% from previous year.
Cellid, Co., Ltd.'s latest quarterly net income in 2024 Q2 was -2.61 Billion KRW , up 20.61% from previous quarter.
Cellid, Co., Ltd. reported an annual net income of -22.86 Billion KRW in 2022, down -74.93% from previous year.
Cellid, Co., Ltd. reported an annual net income of -13.07 Billion KRW in 2021, down -216.78% from previous year.
Cellid, Co., Ltd. reported a quarterly net income of -2.61 Billion KRW for 2024 Q2, up 20.61% from previous quarter.
Cellid, Co., Ltd. reported a quarterly net income of -3.54 Billion KRW for 2023 Q1, up 64.32% from previous quarter.

Annual Net Income Chart of Cellid, Co., Ltd. (2023 - 2015)

Historical Annual Net Income of Cellid, Co., Ltd. (2023 - 2015)

Year	Net Income	Net Income Growth
2023	-11.61 Billion KRW	49.22%
2022	-22.86 Billion KRW	-74.93%
2021	-13.07 Billion KRW	-216.78%
2020	-4.12 Billion KRW	-65.47%
2019	-2.49 Billion KRW	77.91%
2018	-11.28 Billion KRW	-108.69%
2017	-5.4 Billion KRW	-205.28%
2016	-1.77 Billion KRW	-57.47%
2015	-1.12 Billion KRW	0.0%

Year	Net Income	Net Income Growth
2024 Q1	-3.29 Billion KRW	-137.51%
2024 Q2	-2.61 Billion KRW	20.61%
2023 Q1	-3.54 Billion KRW	64.32%
2023 FY	-11.61 Billion KRW	49.22%
2023 Q4	-1.38 Billion KRW	54.91%
2023 Q3	-3.07 Billion KRW	14.84%
2023 Q2	-3.6 Billion KRW	-1.81%
2022 Q4	-9.93 Billion KRW	-152.47%
2022 FY	-22.86 Billion KRW	-74.93%
2022 Q1	-4.82 Billion KRW	0.43%
2022 Q3	-3.93 Billion KRW	5.68%
2022 Q2	-4.17 Billion KRW	13.52%
2021 Q3	-2.9 Billion KRW	-19.54%
2021 Q4	-4.84 Billion KRW	-66.89%
2021 Q1	-2.89 Billion KRW	-80.45%
2021 Q2	-2.42 Billion KRW	16.11%
2021 FY	-13.07 Billion KRW	-216.78%
2020 Q4	-1.6 Billion KRW	-33.81%
2020 Q1	-1.35 Billion KRW	-80.25%
2020 Q2	36.36 Million KRW	102.68%
2020 Q3	-1.19 Billion KRW	-3396.49%
2020 FY	-4.12 Billion KRW	-65.47%
2019 Q1	-425.37 Million KRW	54.79%
2019 FY	-2.49 Billion KRW	77.91%
2019 Q4	-754.15 Million KRW	-28.76%
2019 Q3	-585.69 Million KRW	19.58%
2019 Q2	-728.33 Million KRW	-71.22%
2018 Q2	-2.55 Billion KRW	64.88%
2018 FY	-11.28 Billion KRW	-108.69%
2018 Q1	-7.28 Billion KRW	-456.49%
2018 Q4	-940.87 Million KRW	0.0%
2017 FY	-5.4 Billion KRW	-205.28%
2017 Q1	-1.25 Billion KRW	0.0%
2017 Q4	-1.3 Billion KRW	0.0%
2016 FY	-1.77 Billion KRW	-57.47%
2015 FY	-1.12 Billion KRW	0.0%

Peer Net Income Comparison of Cellid, Co., Ltd.

Name	Net Income	Net Income Difference
Sam Chun Dang Pharm. Co., Ltd	-10.38 Billion KRW	-11.834%
Hyundai Bioscience Co., Ltd.	-14.49 Billion KRW	19.918%
ST Pharm Co.,Ltd.	19.58 Billion KRW	159.299%
ABL Bio Inc.	-2.64 Billion KRW	-338.72%